NGM BIOPHARMACEUTICALS INC Quarterly Unrecognized Tax Benefits in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Ngm Biopharmaceuticals Inc quarterly Unrecognized Tax Benefits history and growth rate from Q4 2016 to Q4 2023.
  • Ngm Biopharmaceuticals Inc Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $54.2M, a 40.1% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $54.2M +$15.5M +40.1% Dec 31, 2023 10-K 2024-03-11
Q4 2022 $38.7M +$12.8M +49.6% Dec 31, 2022 10-K 2024-03-11
Q4 2021 $25.9M +$15.5M +150% Dec 31, 2021 10-K 2024-03-11
Q4 2020 $10.3M +$6.53M +171% Dec 31, 2020 10-K 2024-03-11
Q4 2019 $3.82M $0 0% Dec 31, 2019 10-K 2023-02-28
Q4 2018 $3.82M +$2.29M +150% Dec 31, 2018 10-K 2022-03-01
Q4 2017 $1.53M $0 0% Dec 31, 2017 10-K 2021-03-15
Q4 2016 $1.53M Dec 31, 2016 10-K 2020-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.